{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "41163-599",
      "generic_name": "dextromethorphan hydrobromide, guaifenesin",
      "labeler_name": "United Natural Foods, Inc. dba UNFI",
      "brand_name": "equaline mucus dm",
      "active_ingredients": [
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "30 mg/1"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "600 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "41163-599-01",
          "description": "1 BOTTLE in 1 CARTON (41163-599-01)  / 20 TABLET, EXTENDED RELEASE in 1 BOTTLE",
          "marketing_start_date": "20200218",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "United Natural Foods, Inc. dba UNFI"
        ],
        "rxcui": [
          "1298324"
        ],
        "spl_set_id": [
          "1db69578-2331-4fce-91a4-95c54cb7dc07"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000193956",
          "N0000008867",
          "N0000009560"
        ],
        "pharm_class_epc": [
          "Expectorant [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Respiratory Secretion Viscosity [PE]",
          "Increased Respiratory Secretions [PE]"
        ],
        "unii": [
          "9D2RTI9KYH",
          "495W7451VQ"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, EXTENDED RELEASE",
      "spl_id": "4fc293f4-69f6-4050-a780-bed58bb68671",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20200218",
      "product_id": "41163-599_4fc293f4-69f6-4050-a780-bed58bb68671",
      "application_number": "ANDA207602",
      "brand_name_base": "equaline mucus dm",
      "pharm_class": [
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}